Biotechnology Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana’s Research And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more
Biotechnology Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia – Psyence Biomedical (NASDAQ:PBM) Read more
Cannabis Psychedelics Reform Update: Connecticut’s Decriminalization, Vermont Hearings, Arizona’s Psilocybin Services & More Read more
Biotechnology Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment – Compass Pathways (NASDAQ:CMPS) Read more